Diethylcarbamazine citrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for diethylcarbamazine citrate and what is the scope of patent protection?
Diethylcarbamazine citrate
is the generic ingredient in one branded drug marketed by Lederle and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for diethylcarbamazine citrate.
Summary for diethylcarbamazine citrate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 87 |
| Clinical Trials: | 3 |
| Patent Applications: | 592 |
| DailyMed Link: | diethylcarbamazine citrate at DailyMed |
Recent Clinical Trials for diethylcarbamazine citrate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Case Western Reserve University | Phase 3 |
| Washington University School of Medicine | Phase 3 |
| Regional Hospital of Agboville, Southern Cote d'Ivoire | Phase 3 |
Medical Subject Heading (MeSH) Categories for diethylcarbamazine citrate
Anatomical Therapeutic Chemical (ATC) Classes for diethylcarbamazine citrate
US Patents and Regulatory Information for diethylcarbamazine citrate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lederle | HETRAZAN | diethylcarbamazine citrate | TABLET;ORAL | 006459-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
